Sumoylation: Implications for Neurodegenerative Diseases

被引:46
|
作者
Anderson, Dina B. [1 ]
Zanella, Camila A. [2 ]
Henley, Jeremy M. [3 ]
Cimarosti, Helena [2 ]
机构
[1] Ipsen Bioinnovat Ltd, Units Quadrant 4 10, Barton Lane, Abingdon OX14 3YS, Oxon, England
[2] Univ Fed Santa Catarina, Dept Pharmacol, Campus Univ Trindade, BR-88040900 Florianopolis, SC, Brazil
[3] Univ Bristol, Sch Biochem, MRC Ctr Synapt Plast, Bristol BS8 1TD, Avon, England
基金
英国生物技术与生命科学研究理事会; 英国医学研究理事会; 英国惠康基金;
关键词
Alzheimer's disease; Amyotrophic lateral sclerosis; Ischemia; Neuronal intranuclear inclusion disease; Parkinson's disease; Polyglutamine diseases; Drug targets; INTRANUCLEAR INCLUSION DISEASE; ALPHA-SYNUCLEIN AGGREGATION; FAMILIAL PARKINSONS-DISEASE; MODIFIER SUMO MODIFICATION; A-BETA GENERATION; PROTEIN SUMOYLATION; ENHANCED SUMOYLATION; ALZHEIMERS-DISEASE; ANDROGEN RECEPTOR; MOUSE MODEL;
D O I
10.1007/978-3-319-50044-7_16
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The covalent posttranslational modifications of proteins are critical events in signaling cascades that enable cells to efficiently, rapidly and reversibly respond to extracellular stimuli. This is especially important in the CNS where the processes affecting synaptic communication between neurons are highly complex and very tightly regulated. Sumoylation regulates the function and fate of a diverse array of proteins and participates in the complex cell signaling pathways required for cell survival. One of the most complex signaling pathways is synaptic transmission. Correct synaptic function is critical to the working of the brain and its alteration through synaptic plasticity mediates learning, mental disorders and stroke. The investigation of neuronal sumoylation is a new and exciting field and the functional and pathophysiological implications are far-reaching. Sumoylation has already been implicated in a diverse array of neurological disorders. Here we provide an overview of current literature highlighting recent insights into the role of sumoylation in neurodegeneration. In addition we present a brief assessment of drug discovery in the analogous ubiquitin system and extrapolate on the potential fordevelopment of novel therapies that might target SUMO-associated mechanisms of neurodegenerative disease.
引用
收藏
页码:261 / 281
页数:21
相关论文
共 50 条
  • [1] Sumoylation in neurodegenerative diseases
    Krumova, Petranka
    Weishaupt, Jochen H.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2013, 70 (12) : 2123 - 2138
  • [2] SUMOylation in Neurodegenerative Diseases
    Princz, Andrea
    Tavernarakis, Nektarios
    GERONTOLOGY, 2020, 66 (02) : 122 - 130
  • [3] Sumoylation in neurodegenerative diseases
    Petranka Krumova
    Jochen H. Weishaupt
    Cellular and Molecular Life Sciences, 2013, 70 : 2123 - 2138
  • [4] Role of SUMOylation in Neurodegenerative Diseases
    Mandel, Nicolas
    Agarwal, Nitin
    CELLS, 2022, 11 (21)
  • [5] Mitohormesis; Potential implications in neurodegenerative diseases
    Gohel, Dhruv
    Singh, Rajesh
    MITOCHONDRION, 2021, 56 : 40 - 46
  • [6] Implications of Gut Microbiota in Neurodegenerative Diseases
    Zhang, Haoming
    Chen, Yijia
    Wang, Zifan
    Xie, Gaijie
    Liu, Mingming
    Yuan, Boyu
    Chai, Hongxia
    Wang, Wei
    Cheng, Ping
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [7] TOXICITY OF PRIONS AND PRIONOIDS: IMPLICATIONS IN NEURODEGENERATIVE DISEASES
    Aguzzi, Adriano
    NEUROBIOLOGY OF AGING, 2014, 35 : S1 - S1
  • [8] Clinical implications of extracellular vesicles in neurodegenerative diseases
    Vinaiphat, Arada
    Sze, Siu Kwan
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2019, 19 (09) : 813 - 824
  • [9] Alteration of Sphingolipids in Biofluids: Implications for Neurodegenerative Diseases
    Pujol-Lereis, Luciana M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (14)
  • [10] Iron metabolism in the CNS: implications for neurodegenerative diseases
    Tracey A. Rouault
    Nature Reviews Neuroscience, 2013, 14 : 551 - 564